Showing results (201-210 of 224) with videos related to
Sort By:
Pageof 23
Journal of the International AIDS Society|July 13, 2022
PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration projectConnie L Celum, Elizabeth A Bukusi, Linda Gail Bekker, et al.Plos One|June 3, 2022
High HIV incidence among young women in South Africa: Data from a large prospective studyThesla Palanee-Phillips, Helen V Rees, Kate B Heller, et al.NEJM Evidence|June 13, 2022
Efficacy of single-dose HPV vaccination among young African womenRuanne V Barnabas, Elizabeth R Brown, Maricianah A Onono, et al.Nature Medicine|December 4, 2023
Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year resultsRuanne V Barnabas, Elizabeth R Brown, Maricianah A Onono, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2024
Comparison of Empirically Derived and Model-Based Estimates of Key Population HIV Incidence and the Distribution of New Infections by Population Group in Sub-Saharan AfricaOliver Stevens, Rebecca Anderson, John Stover, et al.Plos One|November 16, 2013
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialOliver Laeyendecker, Michal Kulich, Deborah Donnell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2021
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline FindingsNyaradzo M Mgodi, Simbarashe Takuva, Srilatha Edupuganti, et al.Plos Medicine|September 9, 2025
Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing studyKenneth K Mugwanya, Matilda Saina, Nelly R Mugo, et al.Journal of the International AIDS Society|July 2, 2025
The science at HIVR4P 2024: The era of choice in biomedical HIV preventionBeatriz Grinsztejn, Victor Appay, Linda-Gail Bekker, et al.The Lancet. Infectious Diseases|October 11, 2014
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trialJared M Baeten, Deborah Donnell, Nelly R Mugo, et al.Pageof 23